164 related articles for article (PubMed ID: 12568213)
1. Angiotensin and its inhibition: a nephrologist point of view.
Kalra V; Agarwal SK; Wani M
J Assoc Physicians India; 2002 Oct; 50():1270-80. PubMed ID: 12568213
[No Abstract] [Full Text] [Related]
2. Optimal inhibition of renin angiotensin system to salvage 'at risk' diabetic kidneys--emerging Indian evidence.
Shah SN; Bansode BR; Kamath SA
J Assoc Physicians India; 2004 Mar; 52():183-6. PubMed ID: 15636305
[No Abstract] [Full Text] [Related]
3. Angiotensin II receptor blockade in diabetic nephropathy.
Andersen S
Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
[No Abstract] [Full Text] [Related]
4. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
Andersen NH; Mogensen CE
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
[No Abstract] [Full Text] [Related]
5. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
6. Role of angiotensin II in the progression of diabetic nephropathy-therapeutic implications.
Wiecek A; Chudek J; Kokot F
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v16-20. PubMed ID: 12817060
[No Abstract] [Full Text] [Related]
7. [Diabetic nephropathy].
Metsärinne K
Duodecim; 2003; 119(24):2445-50. PubMed ID: 14870506
[No Abstract] [Full Text] [Related]
8. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
Palmer BF
Nephrol Dial Transplant; 2003 Oct; 18(10):1973-5. PubMed ID: 13679467
[No Abstract] [Full Text] [Related]
10. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
Raij L
Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
Parving HH
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
[No Abstract] [Full Text] [Related]
12. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
Papademetriou V
Am Heart J; 2009 Jun; 157(6 Suppl):S24-30. PubMed ID: 19450721
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the renin-angiotensin system in cardiovascular protection: Is it important to watch your C'ARB' intake?
Strauss MH; Verma S
Can J Cardiol; 2005 May; 21(7):577-80. PubMed ID: 15940355
[No Abstract] [Full Text] [Related]
14. Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.
Gradman AH
Am Heart J; 2009 Jun; 157(6 Suppl):S1-6. PubMed ID: 19450719
[No Abstract] [Full Text] [Related]
15. Managing diabetic nephropathy: recent studies.
Lit YZ; Meyer T
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):111-6. PubMed ID: 16481875
[TBL] [Abstract][Full Text] [Related]
16. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
17. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
18. [Pharmacological prevention and treatment of diabetic nephropathy].
Aitio ML
Duodecim; 1993; 109(6):503-11. PubMed ID: 8062718
[No Abstract] [Full Text] [Related]
19. Angiotensin receptors blockers are preferred to angiotensin-converting inhibitors [corrected].
Feldman L; Weissgarten J
Isr Med Assoc J; 2004 May; 6(5):299-300. PubMed ID: 15151374
[No Abstract] [Full Text] [Related]
20. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
